Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
$8.86−0.53 (-5.64%)
Close on Nov 12, 2026Market cap $457.46MP/E –Yield –
Helus Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Helus Pharma's price to sales ratio was 99.5× on May 31, 2022.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | May 31, 2022 | 99.5× | −78.0 |
| 2021 | Dec 31, 2021 | 177.5× | – |
See a number that looks wrong?